(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More
(Alliance News) - Verici Dx PLC on Friday celebrated the launch of an interactive patient-focused educational tool, named the Patient Journey, to help kidney transplant patients. Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More
(Alliance News) - Verici Dx PLC on Wednesday said it raised GBP280,000 via a retail offer of new shares, in addition to the GBP6.2 million raised via a placing last month. Read More
(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News: Read More
(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News: Read More
(Alliance News) - Verici Dx PLC on Wednesday said it had undergone a fundraise to support the development and commercialisation of its range of clinical products. Read More
(Alliance News) - Verici Dx PLC on Monday said that pricing had been finalised for two of its pre- and post-transplant tests, in line with the group's strategy to "develop and commercialise a complementary suite of ground-breaking products". Read More
(Alliance News) - Verici Dx PLC on Monday celebrated the publication of data from its Tutivia trial, which demonstrated the efficacy of the post-transplant test, in the American Journal of Transplantation. Read More
(Alliance News) - Stock prices in London were higher at midday on Wednesday, as investors reacted to a rapid slowdown in the UK annual inflation rate last month, alongside a cooling of US consumer price pressure and favourable data out of China too. Read More
(Alliance News) - Verici Dx PLC shares jumped on Wednesday after it signed an exclusive global licensing agreement with Thermo Fisher Scientific Inc to further develop an assay for pre-transplant prognostic testing for risk of early kidney rejection. Read More
(Alliance News) - The following is a round-up of earning and trading updates by London-listed companies, issued on Friday and not separately reported by Alliance News: Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More
(Alliance News) - Verici Dx PLC on Monday said it received successful results from its clinical study of Clarava that demonstrate it as a test capable of informing a clear, actionable response from clinicians. Read More
(Alliance News) - The following is a round-up of updates on exposure to Silicon Valley Bank by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More